MARC Record from marc_columbia

LEADER: 14383cam a22005174a 4500
001 5875208
005 20221121210435.0
008 050830s2005 nyua b 101 0 eng
010 $a 2005025343
015 $aGBA584413$2bnb
016 7 $a101256174$2DNLM
016 7 $a013306643$2Uk
019 $a63014176
020 $a157331580X (hbk. : alk. paper)
020 $a1573315818 (pbk. : alk. paper)
035 $a(OCoLC)ocm61404523
035 $a(NNC)5875208
035 $a5875208
040 $aDNLM/DLC$cDLC$dNLM$dBAKER$dUKM$dIXA$dMBB$dNLGGC$dOrLoB-B
042 $apcc
050 00 $aQ11$b.N5 vol. 1054$aRC641.7.T5
060 00 $aW1$bAN626YL v.1054 2005
060 10 $aWH 170$bC774c 2005
082 00 $a500 s$a616.1/52$222
084 $a44.86$2bcl
111 2 $aCooley's Anemia Symposium$n(8th :$d2005 :$cLake Buena Vista, Fla.)
245 10 $aCooley's anemia :$beighth symposium /$cedited by Elliott P. Vichinsky.
260 $aNew York, N.Y. :$bNew York Academy of Sciences,$c2005.
300 $axiv, 526 pages :$billustrations (some color) ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aAnnals of the New York Academy of Sciences ;$vv. 1054
505 00 $tThalassemia : the continued challenge /$rDavid G. Nathan -- $tKeynote address : the challenge of Thalassemia for the developing countries /$rDavid J. Weatherall -- $tChanging patterns of Thalassemia worldwide /$rElliott P. Vichinsky -- $t[alpha]-Thalassemia : Hb H disease and Hb bans hydrops fetalis /$rDavid H. K. Chui -- $tHemoglobin E-[beta]-Thalassemia : progress report from the international study group /$rAnuja Premawardhena, Shanthimala de Silver, Mahinda Arambepola, Nancy F. Olivieri, Elliott P. Vichinsky, Laura Merson, Giulia Muraco, Angela Allen, Christopher Fisher, Timothy Peto and David J. Weatherall -- $tSurvival and complications in Thalassemia /$rC. Borgna-Pignatti, M. D. Cappellini, P. de Stefano, G. C. del Vecchio, G. L. Forni, M. R. Gamberini, R. Ghilardi, R. Origa, A. Piga, M. A. Romeo, H. Zhao and A. Cnaan -- $tRole of intergenic human [gamma]-[delta]-globin sequences in human hemoglobin switching and reactivation of fetal hemoglobin in adult erythroid cells /$rArthur Bank, David O'Neill, Rocio Lopez, Dianne Pulte, Maureen Ward, Simon Mantha and Christine Richardson -- $tIsolation and characterization of hematopoietic transcription factor complexes by in Vivo biotinylation tagging and mass spectrometry /$rFrank Grosveld, Patrick Rodriguez, Natalia Meier, Sanja Krpic, Farzin Pourfarzad, Petros Papadopoulos, Katarzyna Kolodziej, George P. Patrinos, Arnd Hostert and John Strouboulis -- $tGermline epimutation : a basis for epigenetic disease in humans /$rDavid I. K. Martin, Robyn Ward and Catherine M. Suter -- $tProgress toward the genetic treatment of the [beta]-Thalassemias /$rMichel Sadelain, Leszek Lisowski, Selda Samakoglu, Stefano Rivella, Chad May and Isabelle Riviere -- $tUnderstanding [alpha]-globin gene regulation : aiming to improve the management of Thalassemia /$rD. R. Higgs, D. Garrick, E. Anguita, M. de Gobbi, J. Hughes, M. Muers, D. Vernimmen, K. Lower, M. Law, A. Argentaro, M. A. Deville and R. Gibbons -- $tRole of alpha hemoglobin-stabilizing protein in normal erythropoiesis and [beta]-Thalassemia /$rMitchell J. Weiss, Suiping Zhou, Liang Feng, David A. Gell, Joel P. MacKay, Yigong Shi and Andrew J. Gow -- $tRole of iron in inducing oxidative stress in Thalassemia : can it be prevented by inhibition of absorption and by autioxidants? /$rEliezer A. Rachmilewitz, Orly Weizer-Stern, Konstantin Adamsky, Ninette Amariglio, Gideon Rechavi, Laura Breda, Stefano Rivella and Z. Ioav Cabantchik -- $tObjectives and mechanism of iron chelation therapy /$rChaim Hershko, Gabriela Link, Abraham M. Konijn and Z. Ioav Cabantchik -- $tFerritin as an iron concentrator and chelator target /$rXiaofeng Liu and Elizabeth C. Theil -- $tThe design of orally active iron chelators /$rRobert C. Hider and Tao Zhou -- $tRecent insights into interactions of deferoxamine with cellular and plasma iron pools : implications for clinical use /$rJ. B. Porter, R. Rafique, S. Srichairatanakool, B. A. Davis, F. T. Shah, T. Hair and P. Evans -- $tDeferiprone : new insight /$rA. Piga, S. Roggero, T. Vinciguerra, L. Sacchetti, V. Gallo and F. Longo -- $tCombined therapy with deferroxamine and deferiprone /$rAntonis Kattamis -- $tEvaluation of ICL670, a once-daily oral iron chelator in a phase III clinical trial of [beta]-Thalassemia patients with transfusional iron overload /$rRenzo Galanello -- $tUnrelated bone marrow transplantation for [beta]-Thalassemia patients : the experience of the Italian bone marrow transplant group /$rGiorgio La Nasa, Franca Argiolu, Claudio Giardini, Andrea Pession, Franca Fagioli, Giovanni Caocci, Adriana Vacca, Piero de Stefano, Eugenia Piras, Antonio Ledda, Antonio Piroddi, Roberto Littera, Sonia Nesci and Franco Locatelli -- $tBone marrow transplantation in adults with Thalassemia : treatment and long-term follow-up /$rJavid Gaziev, Pietro Sodani, Paola Polchi, Marco Andreani and Guido Lucarelli -- $tSibling donor cord blood transplantation for Thalassemia major : experience of the sibling donor cord blood program /$rMark C. Walters, Lynn Quirolo, Elizabeth T. Trachtenberg, Sandie Edwards, Lisa Hale, Joanna Lee, Joi Morton-Wiley, Keith Quirolo, Shanda Robertson, Julie Saba and Bert Lubin -- $tStem cell transplantation with S-59 photochemically treated T-cell add-backs to establish allochimerism in Murine Thalassemia /$rFrans A. Kuypers, Gordon Watson, Ezra Sage, Mark C. Walters, James Hamrick and John E. Hearst -- $tPreimplantation genetics : improving access to stem cell therapy /$rAnver Kuliev, Svetlana Rechitsky, Ilan Tur-Kaspa and Yury Verlinsky -- $tPharmacological induction of fetal hemoglobin : why haven't we been more successful in Thalassemia? /$rHassana Fathallah, Millicent Sutton and George F. Atweh -- $tSuccessful correction of the human Cooley's anemia [beta]-Thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator /$rPunam Malik, Paritha I. Arumugam, Jing-Kuan Yee and Geetha Puthenveetil -- $tSingle and combination plug therapy for fetal hemoglobin augmentation in hemoglobin E-[beta][superscript 0]-Thalassemia : considerations for treatment /$rSylvia T. Singer, Frans A. Kuypers, Nancy F. Olivieri, David J. Weatherall, Robert Mignacca, Thomas D. Coates, Sally Davies, Nancy Sweeters and Elliott P. Vichinsky /$rThe E./[beta][superscript 0]-Thalassemia Study Group -- $tInduction of fetal globin in [beta]-Thalassemia : cellular obstacles and molecular progress /$rSusan P. Perrine, Serguei A. Castaneda, Michael S. Boosalis, Gary L. White, Brandon M. Jones and Regine Bohacek -- $tCaring for adults with Thalassemia in a pediatric world /$rLaurice M. Compagno -- $tQuality of life in Thalassemia /$rP. Telfer, G. Constantinidou, P. Andreou, S. Christou, B. Modell and M. Angastiniotis -- $tThalassemia and learning : neurocognitive function in children /$rF. Daniel Armstrong -- $tTreatment of hepatitis C virus infection in Thalassemia /$rEllen Butensky, Zahra Pakbaz, Drucilla Foote, Mark C. Walters, Elliott P. Vjchinsky and Paul Harmatz -- $tFertility and pregnancy in Thalassemia major /$rSusan M. Tuck -- $tA phase I/II clinical trial of [beta]-globin gene therapy for [beta]-Thalassemia /$rArthur Bank, Ronald Dorazio and Philippe Leboulch -- $tCoagulation and splenectomy : an overview /$rM. D. Cappellini, E. Grespi, E. Cassinerio, D. Bignamini and G. Fiorelli -- $tTransfusion safety : where are we today? /$rNaomi L. C. Luban -- $tPulmonary hypertension in [beta]-Thalassemia /$rAthanasios Aessopos and Dimitrios Farmakis -- $tMonitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometry /$rRoland Fischer, Antonio Piga, Paul Harmatz and Peter Nielsen -- $tMethods for noninvasive measurement of tissue iron in Cooley's anemia /$rSujit Sheth, Haiying Tang, Jens H. Jensen, Karen Altmann, Ashwin Prakash, Beth F. Printz, Alan J. Hordof, Christina L. Tosti, Andjela Azabagic, Srirama Swaminathan, Truman R. Brown, Nancy F. Olivieri and Gary M. Brittenham -- $tT2* magnetic resonance and myocardial iron in Thalassemia /$rDudley J. Pennell -- $tMeasurement and mapping of liver iron concentrations using magnetic resonance imaging /$rTimothy G. St. Pierre, Paul R. Clark and Wanida Chua-Anusorn -- $tPhysiology and pathophysiology of iron cardiomyopathy in Thalassemia /$rJohn C. Wood, Cathleen Enriquez, Nilesh Ghugre, Maya Otto-Duessel, Michelle Aguilar, Marvin D. Nelson, Rex Moats and Thomas D. Coates -- $tEighth Cooley's anemia symposium : summation and perspective /$rArthur W. Nienhuis -- $tRescued mice with Hb E transgene-developed red cell changes similar to human [beta]-Thalassemia/HbE disease /$rBundit Wannasuphaphol, Ruchaneekorn Kalpravidh, Kovit Pattanapanyasat, Panos Ioannau, Frans A. Kuypers, Suthat Fucharoen and Pranee Winichagoon -- $tExploring the role of hepcidin, an antimicrobial and iron regulator peptide, in increased iron absorption in [beta]-Thalassemia /$rLaura Breda, Sara Gardenghi, Ella Guy, Eliezer A. Rachmilewitz, Orly Weizer-Stern, Konstantin Adamsky, Ninette Amariglio, Gideon Rechavi, Patricia J. Giardina, Robert W. Grady and Stefano Rivella --
500 $a"Eighth Cooley's Anemia Symposium ... held on March 17-19, 2005 in Lake Buena Vista, Florida"--Contents p.
504 $aIncludes bibliographical references and index.
505 80 $tMurine and math models for the level of stable mixed chimerism to cure [beta]-Thalassemia by nonmyeloablative bone marrow transplantation /$rCarla Roberts, Leslie Kean, David Archer, Can Balkan and Lewis L. Hsu -- $tNon-transferrin-bound iron during blood transfusion cycles in [beta]-Thalassemia major /$rRegine Grosse, Ulrike Lund, Vincenzo Caruso, Roland Fischer, Gritta E. Janka, Carmelo Magnano, Rainer Engelhardt, Matthias Durken and Peter Nielsen -- $tGenetic analysis of candidate modifier polymorphisms in HbE-[beta][superscript 0]-Thalassemia patients /$rOrapan Sripichai, Johanna Whitacre, Thongperm Munkongdee, Chutima Kumkhaek, Wattanan Makarasara, Pranee Winichagoon, Ken Abel, Andreas Braun and Suthat Fucharoen -- $tMeasuring chromosome breaks in patients with Thalassemia /$rTal Offer, Amrita Bhagat, Ashutosh Lal, Wafa Atamna, Sylvia T. Singer, Elliott P. Vichinsky, Frans A. Kuypers and Bruce N. Ames -- $tLongitudinal study of survival and causes of death in patients with Thalassemia major in Greece /$rVassilis Ladis, George Chouliaras, Helen Berdousi, Emmanuel Kanavakis and Christos Kattamis -- $tOsteoporosis in [beta]-Thalassemia : clinical and genetic aspects /$rR. Origa, E. Fiumana, M. R. Gamberini, S. Armari, M. Mottes, A. Sangalli, E. Paglietti, R. Galanello and C. Borgna-Pignatti -- $tQuality of life in patients with Thalassemia intermedia compared to Thalassemia major /$rZahra Pakbaz, Marsha Treadwell, Robert Yamashita, Keith Quirolo, Drucilla Foote, Laura Quill, Titi Singer and Elliott P. Vichinsky -- $tLow bone mineral density in adolescents with [beta]-Thalassemia /$rMaria G. Vogiatzi, Karen A. Autio, Jeffrey E. Mait, Robert Schneider, Martin Lesser and Patricia J. Giardina -- $tDoes heterozygous [beta]-Thalassemia confer a protection against coronary artery disease? /$rStergios Tassiopoulos, Spyros Deftereos, Kostas Konstantopoulos, Dimitris Farmakis, Maria Tsironi, Michalis Kyriakidis and Athanassios Aessopos -- $tTherapeutic approaches to pulmonary hypertension in hemoglobinopathies : efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathy /$rGiorgio Derchi and Gian Luca Forni -- $tUtility of Holter electrocardiogram in iron-overloaded hemoglobinopathies /$rNaveen Qureshi, Kishor Avasarala, Drucilla Foote and Elliott P. Vichinsky -- $tHemolysis-associated pulmonary hypertension in Thalassemia /$rClaudia R. Morris, Frans A. Kuypers, Gregory J. Kato, Lisa Lavrisha, Sandra Larkin, Titi Singer and Elliott P. Vichinsky -- $tA simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with Thalassemia /$rZahra Pakbaz, Roland Fischer, Marsha Treadwell, Robert Yamashita, Ellen B. Fung, Lisa Calvelli, Keith Quirolo, Drucilla Foote, Paul Harmatz and Elliott P. Vichinsky -- $tPreclinical and clinical development of deferitrin, a novel, orally available iron chelator /$rJoanne M. Donovan, Melissa Plone, Rafif Dagher, Mark Bree and Judith Marquis -- $tAllosensitization in patients receiving multiple blood transfusions /$rV. S. Sakhalkar, K. Roberts, L. M. Hawthorne, D. M. McCaskill, D. M. Veillon, G. C. Caldito and J. D. Cotelingam -- $tOutcomes of preimplantation genetic diagnosis therapy in treatment of [beta]-Thalassemia : a retrospective analysis /$rNaveen Qureshi, Drucilla Foote, Mark C. Walters, Sylvia T. Singer, Keith Quirolo and Elliott P. Vichinsky -- $tSeparation of normoblasts from whole blood by ultracentrifugation on Arabino-Galactane discontinuous gradients : a tool for prenatal diagnosis /$rSergio Piomelli, Daniel Hirsch and Lawrence Corash -- $tPrenatal diagnosis of hemoglobinopathies in Ontario, Canada /$rRaveen K. Basran, Margie Patterson, Lynda Walker, Lisa M. Nakamura, Barry Eng, David H. K. Chui and John S. Waye -- $tThe splenectomy controversy /$rSergio Piomelli -- $tDiagnosis and management of alpha Thalassemia disorders /$rFred Lorey -- $tManagement of the "difficult" iron-overloaded patient /$rMarie Boorman Martin -- $tGenotypes and phenotypes of Thalassemia : a discussion /$rSuthat Fucharoen -- $tNutrition : role in health and therapy /$rVirginia A. Stallings.
650 0 $aThalassemia$vCongresses.
653 1 $aCooley's anaemia
650 12 $abeta-Thalassemia.$0https://id.nlm.nih.gov/mesh/D017086
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
650 17 $aThalassemie.$2gtt
700 1 $aVichinsky, Elliott P.$0http://id.loc.gov/authorities/names/no2003023609
710 2 $aNew York Academy of Sciences.$0http://id.loc.gov/authorities/names/n79032973
830 0 $aAnnals of the New York Academy of Sciences ;$vv. 1054.$0http://id.loc.gov/authorities/names/n42032359
856 41 $3Table of contents$uhttp://www.loc.gov/catdir/toc/ecip0518/2005025343.html
852 00 $boff,sci$hQ11$i.N42 v.1054